Enoxaparin, effective dosage for intensive care patients: double-blinded, randomised clinical trial

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism1999 · 107 citations
2. 2The Relationship between Anti-Factor Xa Level and Clinical Outcome in Patients Receiving Enoxaparine Low Molecular Weight Heparin to Prevent Deep Vein Thrombosis after Hip Replacement1989 · 214 citations
3. 3Diagnostic Significance of Thrombin-Antithrombin III Complex (TAT) and D-Dimer in Patients With Deep Venous Thrombosis1996 · 14 citations
4. 4Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency2005 · 76 citations
5. 5Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors2008 · 94 citations